Merck & Co., Inc. (TSX:MRK)
26.76
+0.60 (2.29%)
At close: Feb 4, 2026
17.16% (1Y)
| Market Cap | 401.66B +15.0% |
| Revenue (ttm) | 89.14B +1.3% |
| Net Income | 25.03B +6.6% |
| EPS | 9.98 +8.0% |
| Shares Out | n/a |
| PE Ratio | 16.05 |
| Forward PE | 22.95 |
| Dividend | 0.74 (2.78%) |
| Ex-Dividend Date | Dec 15, 2025 |
| Volume | 4,026 |
| Average Volume | 5,485 |
| Open | 26.17 |
| Previous Close | 26.16 |
| Day's Range | 26.17 - 27.02 |
| 52-Week Range | 16.84 - 27.02 |
| Beta | n/a |
| RSI | 73.62 |
| Earnings Date | Feb 3, 2026 |